Elon Musk Is Back Working With the U.S. Government. Why That Could Be Trouble for SpaceX's Stock

Elon Musk will co-lead Project Meridian, a U.S. Department of War taskforce planned to run for 120 days and study capabilities for next-generation warfare. The article warns that negative press around Musk’s government role could weigh on SpaceX, valued at $2.2 trillion and described as unprofitable, because its valuation depends heavily on growth expectations and Musk’s leadership. It cites Tesla’s 34% decline from Jan. 20 to Apr. 30, 2025, during Musk’s involvement with DOGE, versus a 7% drop in the S&P 500, as a prior example—not a forecast for SpaceX.

Analysis

The key asymmetry is not simply reputational spillover: closer public-sector involvement could expand strategic relevance while increasing scrutiny of procurement, conflicts, and executive conduct. That creates a two-sided catalyst for SpaceX; negative headlines may pressure a valuation built on long-duration expectations, while demonstrable government adoption could reinforce the strategic premium. Any benefit to defense incumbents such as RTX, Northrop Grumman, or L3Harris would depend on procurement design and whether programs favor established integrators over newer providers—not follow automatically from the initiative.

The near-term risk is sentiment and headline volatility; the more consequential 1–3 month test is whether the project produces concrete requirements, contracts, or governance scrutiny. Over 6–18 months, execution, contract economics, and funding of growth matter more than CEO headlines. The article’s valuation and profitability claims should be independently verified against consolidated financials and security terms before sizing a position; neither is enough by itself to establish downside.

Contrarian point: a government role could be a commercial credibility signal, so treating all association with government as negative risks missing upside. Conversely, a temporary sentiment rebound would not resolve valuation risk. No clean TSLA hedge follows from this event: shared CEO exposure does not ensure the two securities move together.

Key Decisions for Investors

• For existing SPCX exposure, review concentration and downside tolerance now; do not add solely on the strategic-government narrative. Verify security liquidity, available hedges, and consolidated financial disclosures first.
• Treat a defined-risk SPCX put spread as a conditional hedge—not a standing short—only if options are sufficiently liquid and pricing is acceptable. Reassess after project milestones and any company disclosures; maximum loss is the premium.
• Watch for concrete procurement requirements, contract awards, or formal conflict-of-interest and oversight actions over the next 1–3 months. These are more decision-useful than headline volume alone.
• Falsify the bearish sentiment thesis if scrutiny remains limited and verifiable contract or operating disclosures support expectations; strengthen it if oversight escalates or company disclosures show weaker execution or economics than the valuation requires.